This section contains 76 words (approx. 1 page at 300 words per page) |
Porter Warren Anderson Jr. for groundbreaking work in the development and commercialization of the Hemophilus influenza type b vaccine. David H. Smith for visionary leadership in bringing the life-saving Hemophilus influenza type b vaccine to the world market. John B. Robbins for bold and imaginative leadership in developing polysaccharide conjugate vaccine against Hemophilus influenza type b. Rachael Schneerson for pioneering discoveries in vaccines leading to the eradication of Hemophilus influenza type b, typhoid, and pneumococcus.
This section contains 76 words (approx. 1 page at 300 words per page) |